apigenin and Dermatitis--Contact

apigenin has been researched along with Dermatitis--Contact* in 7 studies

Reviews

1 review(s) available for apigenin and Dermatitis--Contact

ArticleYear
Complementary, holistic, and integrative medicine: chamomile.
    Pediatrics in review, 2007, Volume: 28, Issue:4

    Topics: Chamomile; Colic; Conjunctivitis; Cyclosporine; Dermatitis; Dermatitis, Contact; Diarrhea; Dyspepsia; Female; Flowers; Herb-Drug Interactions; Humans; Infant; Lactation; Morning Sickness; Phytotherapy; Plant Extracts; Plant Preparations; Pregnancy; Warfarin

2007

Trials

1 trial(s) available for apigenin and Dermatitis--Contact

ArticleYear
[Comparative testing of Kamillosan cream and steroidal (0.25% hydrocortisone, 0.75% fluocortin butyl ester) and non-steroidal (5% bufexamac) dermatologic agents in maintenance therapy of eczematous diseases].
    Zeitschrift fur Hautkrankheiten, 1985, Feb-01, Volume: 60, Issue:3

    We report on 161 patients suffering from inflammatory dermatoses on hands, forearms, and lower legs who had been initially treated with 0.1% difluocortolone valerate. During the maintenance therapy carried out over a period of 3 to 4 weeks, we tested the efficacy of Kamillosan cream vs. 0.25% hydrocortisone, 0.75% fluocortin butyl ester, and 5% bufexamac in a bilateral comparative study. For the indications tested Kamillosan cream showed more or less equieffective therapeutic results as compared to 0.25% hydrocortisone. It is superior, however, to the non-steroidal anti-inflammatory agent 5% bufexamac as well as to 0.75% fluocortin butyl ester, a further glucocorticoid. With regard to neurodermitis, Kamillosan cream not only shows the same therapeutic effect as 0.25% hydrocortisone but is even of marked superiority towards other reference products.

    Topics: Adolescent; Adult; Aged; Bufexamac; Chamomile; Clinical Trials as Topic; Dermatitis; Dermatitis, Contact; Dermatitis, Seborrheic; Diflucortolone; Female; Fluocortolone; Humans; Hydrocortisone; Hydroxamic Acids; Male; Middle Aged; Neurodermatitis; Oils, Volatile; Ointments; Plant Extracts; Plants, Medicinal

1985

Other Studies

5 other study(ies) available for apigenin and Dermatitis--Contact

ArticleYear
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
    Science translational medicine, 2019, 07-10, Volume: 11, Issue:500

    There is a major clinical need for new therapies for the treatment of chronic itch. Many of the molecular components involved in itch neurotransmission are known, including the neuropeptide NPPB, a transmitter required for normal itch responses to multiple pruritogens in mice. Here, we investigated the potential for a novel strategy for the treatment of itch that involves the inhibition of the NPPB receptor NPR1 (natriuretic peptide receptor 1). Because there are no available effective human NPR1 (hNPR1) antagonists, we performed a high-throughput cell-based screen and identified 15 small-molecule hNPR1 inhibitors. Using in vitro assays, we demonstrated that these compounds specifically inhibit hNPR1 and murine NPR1 (mNPR1). In vivo, NPR1 antagonism attenuated behavioral responses to both acute itch- and chronic itch-challenged mice. Together, our results suggest that inhibiting NPR1 might be an effective strategy for treating acute and chronic itch.

    Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries

2019
Preparation of novel apigenin-enriched, liposomal and non-liposomal, antiinflammatory topical formulations as substitutes for corticosteroid therapy.
    Phytotherapy research : PTR, 2011, Volume: 25, Issue:2

    Two oil-in-water formulations, containing equal amounts of apigenin-enriched chamomile flower extracts, for potential use as topical antiinflammatory agents, were prepared and their physicochemical properties evaluated. A pilot clinical study was then carried out to assess patient acceptability and efficacy. The creams were either non-liposomal or liposomal. The liposomal formulations were more viscous, thus producing superior release characteristics in vitro. The clinical study also showed that the liposomal creams were, as antiinflammatory agents, slightly more effective in vivo than the non-liposomal formulations. These results suggest that there is scope for the further development of even more effective and safer alternatives to corticosteroids.

    Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Apigenin; Chamomile; Dermatitis, Contact; Humans; Liposomes; Middle Aged; Ointments; Phytotherapy; Pilot Projects; Plant Extracts; Skin

2011
Allergic contact dermatitis of the nipple from Roman chamomile ointment.
    Contact dermatitis, 1991, Volume: 24, Issue:2

    Topics: Adult; Breast Feeding; Chamomile; Dermatitis, Contact; Female; Flavonoids; Humans; Nipples; Oils, Volatile; Ointments; Plants, Medicinal

1991
[Profilometry, a method for the assessment of the therapeutic effectiveness of Kamillosan ointment].
    Zeitschrift fur Hautkrankheiten, 1988, Mar-21, Volume: 63, Issue:3

    Experimentally induced toxic contact dermatitis was topically treated with 3 different ointments (Kamillosan ointment, Kamillosan ointment base. 0.1% hydrocortisone acetate). The structural changes of the epidermal surface were studied by means of profilometry. According to our results, Kamillosan ointment is remarkably superior to other reference products with regard to its soothing effect on human skin.

    Topics: Chamomile; Dermatitis, Contact; Drug Combinations; Humans; Oils, Volatile; Ointments; Plant Extracts; Plants, Medicinal; Sesquiterpenes; Skin; Wound Healing

1988
Allergy to Matricaria chamomilla.
    Contact dermatitis, 1987, Volume: 16, Issue:1

    Topics: Chamomile; Dermatitis, Contact; Dermatitis, Occupational; Facial Dermatoses; Female; Humans; Middle Aged; Oils, Volatile; Plant Extracts; Plants, Medicinal

1987